Details of the Drug

General Information of Drug (ID: DMBXA95)

• Drug Name: VERU-111
• Synonyms: [2-(1H-indol-3-yl)-1H-imidazol-5-yl](3,4,5-trimethoxyphenyl)methanone; SCHEMBL724794; SCHEMBL20850747; CHEMBL2163631; WQGVHOVEXMOLOK-UHFFFAOYSA-N; HY-120599; CS-0078414; KUM; 1332881-26-1

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 2	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C21H19N3O4
  Canonical SMILES: COC1=CC(=CC(=C1OC)OC)C(=O)C2=CN=C(N2)C3=CNC4=CC=CC=C43
  InChI: InChI=1S/C21H19N3O4/c1-26-17-8-12(9-18(27-2)20(17)28-3)19(25)16-11-23-21(24-16)14-10-22-15-7-5-4-6-13(14)15/h4-11,22H,1-3H3,(H,23,24)
  InChIKey: WQGVHOVEXMOLOK-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 53379371
  TTD ID: D0DD8T
• Drug-Molecule Activity Atlas (DMA)NEW: Click to Jump to the Detailed DMA Information of This Drug
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug

References

• [1] VERU-111, an Oral, Next Generation, First-In-Class Small Molecule for the Potential Treatment of COVID-19. May 15, 2020.